Nature is our blueprint
Nature is our blueprint. Today, we re-engineer naturally occurring peptides to treat inflammatory and fibrotic diseases. Tomorrow, we aim to extend healthspan. We are an AI-native drug development company combining computational design with deep translational and clinical experience. We pursue targets that have resisted conventional approaches, where precision peptides can make the biggest difference for patients.